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METHODS
INTRODUCTION
• The A. gossypii Agura3 uracil auxotroph, which presents a riboflavin overproducing phenotype, is unable to grow at the
same level of the parent strain when the medium is supplemented with uracil alone, being necessary the addition of
uridine to overcome this effect1.
• A similar effect was also reported for other flavinogenic fungi, such as Pichia guilliermondii (Candida guilliermondii)2 and
also for some species of the protozoan parasites Leishmania3.
• The fluorinated analog of cytosine (5-Flucytosine; 5-FC) is a drug with antifungal properties commonly used against
Candida albicans. Increased resistance to this drug by some strains was associated with a point mutation in the FUR1
gene of the salvage pathway of pyrimidine ribonucleotides4.
• Given the importance of uracil auxotrophic strains, it is of extreme pertinence to elucidate the determinants behind this
inadequacy of uracil to rescue the growth of flavinogenic uracil auxotrophs.
• In this work we investigated the suitability of intermediates of the pyrimidine ribonucleotides salvage
pathway to rescue the growth of A. gossypii Agura3. Based on these results, we identified the reaction
catalyzed by the enzyme encoded by the gene AgFur1 (Fig. 1) as the potential limiting step of this
pathway in A. gossypii and this hypothesis was tested by analyzing its resistance to 5-FC.
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CONCLUSIONS
1. URIDINE CAN PROPERLY RESCUE THE GROWTH OF A. gossypii Agura3 WHEREAS URACIL AND CYTOSINE CANNOT
2. THE BEST GROWTH PARAMETERS ACHIEVED BY A. gossypii Agura3 ARE WITH SUPPLEMENTATION OF 5 MM URIDINE
3. CONNECTING POOR UTILIZATION OF URACIL BY A. gossypii Agura3 WITH 5-FC RESISTANCE VIA THE AGFUR1 GENE
• Uridine can properly rescue the growth of A. gossypii Agura3 strain whereas uracil, cytosine and cytidine cannot.
Therefore, uridine is the most adequate growth supplementation for A. gossypii uracil/uridine auxotrophic strains.
• Based on the results of the spot dilution assay, the growth of A. gossypii is apparently less affected by the drug 5-FC
than that of S. cerevisiae, corroborating the hypothesis that the reaction catalyzed by the AgFUR1p is a limiting step
in the salvage pathway of pyrimidine ribonucleotides in A. gossypii.
• Currently, we are performing the recombinant production, purification and molecular characterization of AgFur1p in
order to further elucidate this phenotype of A. gossypii uracil/uridine auxotrophs and confirm our hypothesis.
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Figure 1 – Schematic representation indicating the de novo and salvage pathways of pyrimidine ribonucleotides. The × marks
where the pyrimidine biosynthetic pathway is blocked in the A. gossypii Agura3 uridine/uracil auxotrophic strain. In blue, the
accepted mechanisms of action of the drug 5-Flucytosine (5-FC) and the respective deleterious effects for the cell. 5-FU, 5-
Fluorouracil. Dashed arrows represent several reactions.
1. RADIAL GROWTH CURVE OF A. gossypii Agura3 STRAINS ON DIFFERENT MEDIA SUPPLEMENTED WITH
DIFFERENT PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES
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- A. gossypii Agura3 is an uracil/uridine auxotrophic strain derived from the reference strain A. gossypii ATCC10895. 
- SCD, synthetic complete medium with amino acids and without uracil, uridine or cytosine (glucose, yeast nitrogen base (YNB) and 
CaCO3); MM, minimal medium (glucose, YNB and CaCO3); AFM, Ashbya Full Medium (glucose, tryptone, yeast extract and myo-
inositol). All media contained agar.
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2. GROWTH PARAMETERS OF A. gossypii Agura3 GROWING ON MEDIA SUPPLEMENTED WITH DIFFERENT
CONCENTRATIONS OF PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES
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3. 5-FLUCYTOSINE RESISTANCE OF A. gossypii AND S. cerevisiae STRAINS TESTED BY SPOT DILUTION
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- Strains used: A. gossypii ATCC10895 and S. cerevisiae CENPK113-7D (wild type); A. gossypii Agura3 and S. cerevisiae CENPK113-
5D (uracil/uridine auxotrophic strains).
- Cells or spores were counted using a Neubauer Chamber and the 100 dilution concentration were defined to 106 spores or cells per 
mL. 10x serial dilutions were made until the 10-4 dilution. Subsequently, 10 µl from each dilution were inoculated on the plates.
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• Uridine can be metabolized directly to UMP via AgURK1p (Fig. 1) instead of passing the uridine à uracilà UMP reactions.
• On the other hand, uracil and cytosine must be metabolized through uracilà UMP reaction, while cytidine can take both routes.
• Therefore, the reaction catalyzed by AgFUR1p may possibly be the limiting step in A. gossypii. Especially because it requires PRPP,
a precursor also necessary for the A. gossypii's highly active purine biosynthetic pathway.
• Low activity of the enzyme involved in this reaction (AgFUR1p) can block the salvage pathway of pyrimidine ribonucleotides,
leading to an accumulation of uracil and consequently impairment of the growth of A. gossypii Agura3.
• Since 5-FC needs to be metabolized in order to produce its effect, its toxicity is directly related with the activity of AgFUR1p.
Hypothesis
If the reaction catalyzed by the AgFUR1p is a limiting step,
A. gossypii should present increased resistance to the drug 5-FC
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Uridine
1 mM 10.5 ± 1.2 3
4 mM 10.8 ± 0.1 2
5 mM 13.3 ± 0.0 2
Uracil
1 mM 5.5 ± 0.5 3
4 mM 2.8 ± 0.2 3
5 mM – 7
Cytosine
1 mM – 8
4 mM 4.0 ± 0.3 5
5 mM 6.5 ± 0.6 4
Cytidine
1 mM 6.9 ± 1.3 5
4 mM 7.2 ± 0.6 3
5 mM 7.0 ± 1.2 3
The concentrations of uracil, uridine and cytosine used did not 
negatively affect the growth of the A. gossypii parent type strain.
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- The percentage of relative growth of Agura3 strain was determined by normalizing the maximum radial growth  of each condition to the 
growth in the condition that results in the highest growth (5 mM uridine).
- Relative growth
- Radial growth rate
- Lag phase
- Radial growth curves
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